https://www.ukhealthcaregazette.com/article/907744068-kfsh-advances-precision-surgery-through-in-house-3d-printing-program UK Healthcare Gazette en PressRelease 2026-04-25T23:00:00+00:00 KFSH Advances Precision Surgery Through In-House 3D Printing Program https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24840352-3d-printing-card-4096x2731.jpeg https://www.ukhealthcaregazette.com/article/908039883-xylitol-market-report-2026-business-growth-development-factors-current-and-future-trends-till-2030 UK Healthcare Gazette en PressRelease 2026-04-25T18:02:48+00:00 Xylitol Market Report 2026| Business Growth, Development Factors, Current and Future Trends till 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24840866-xylitol-market-segments-1920x1080.png https://www.ukhealthcaregazette.com/article/908058136-ear-worn-core-temp-sensor-market-cagr-to-be-at-12-9-from-2026-to-2030-1-34-billion-industry-revenue-by-2030 UK Healthcare Gazette en PressRelease 2026-04-25T18:02:22+00:00 Ear-Worn Core-Temp Sensor Market CAGR to be at 12.9% from 2026 to 2030 | $1.34 Billion Industry Revenue by 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24840936-ear-worn-core-temp-sensor-marke-1920x1080.png https://www.ukhealthcaregazette.com/article/905963305-theom-redefines-ai-data-security-placing-as-a-leader-across-major-industry-analyst-evaluations UK Healthcare Gazette en PressRelease 2026-04-24T15:51:15+00:00 Theom Redefines AI & Data Security, Placing as a Leader Across Major Industry Analyst Evaluations https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838636-logo-with-tagline-4050x1796.png https://www.ukhealthcaregazette.com/article/907742964-kfsh-scales-genomic-medicine-from-research-to-clinical-decision-making UK Healthcare Gazette en PressRelease 2026-04-24T14:04:32+00:00 KFSH Scales Genomic Medicine from Research to Clinical Decision-Making https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23824068-genom-302x167.jpeg https://www.ukhealthcaregazette.com/article/907730339-kfsh-cmo-named-first-hospital-marketing-representative-globally-on-cannes-lions-jury UK Healthcare Gazette en PressRelease 2026-04-24T12:50:19+00:00 KFSH CMO Named First Hospital Marketing Representative Globally on Cannes Lions Jury https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24840306-muhanned-kadi-4096x4096.jpeg https://www.ukhealthcaregazette.com/article/907644546-pitpat-launches-chase-the-sun-global-virtual-running-event-redefining-digital-fitness-experience UK Healthcare Gazette en PressRelease 2026-04-24T12:00:00+00:00 PitPat Launches 'Chase the Sun' Global Virtual Running Event, Redefining Digital Fitness Experience https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23156496-deerrun4-3840x1700.jpeg https://www.ukhealthcaregazette.com/article/907699695-medicated-skincare-market-size-to-hit-usd-77-26-billion-by-2033-says-coherent-market-insights UK Healthcare Gazette en PressRelease 2026-04-24T10:00:28+00:00 Medicated Skincare Market Size to Hit USD 77.26 Billion by 2033, says Coherent Market Insights https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24840187-medicated-skincare-market-1024x1024.jpeg https://www.ukhealthcaregazette.com/article/907891379-performance-lab-under-investigation-premium-grade-nutritional-supplements-with-research-backed-ingredients-that-work UK Healthcare Gazette en PressRelease 2026-04-24T21:46:40+00:00 Performance Lab Under Investigation: Premium-Grade Nutritional Supplements with Research-Backed Ingredients That Work https://zingfast.com/wp-content/uploads/2026/04/Performance-Lab-Supplements.jpg https://www.ukhealthcaregazette.com/article/907276592-pride-mobility-s-jazzy-assist-introduces-ez-pass-ai-to-redefine-everyday-mobility UK Healthcare Gazette en PressRelease 2026-04-24T09:30:00+00:00 Pride Mobility’s Jazzy Assist Introduces EZ-Pass™ AI to Redefine Everyday Mobility https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838106-product-shot-2500x1599.png https://www.ukhealthcaregazette.com/article/907678405-how-bone-marrow-fat-drives-immune-suppression-and-bone-loss-in-obesity UK Healthcare Gazette en PressRelease 2026-04-24T07:17:36+00:00 How Bone Marrow Fat Drives Immune Suppression and Bone Loss in Obesity https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24840090-bone-marrow-fat-driven-immune-s-571x341.jpeg https://www.ukhealthcaregazette.com/article/907666366-any-run-expands-free-access-to-threat-intelligence-for-soc-and-mssp-teams UK Healthcare Gazette en PressRelease 2026-04-24T05:45:23+00:00 ANY.RUN Expands Free Access to Threat Intelligence for SOC and MSSP Teams https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/21089858-new-logo-1000x1000.png https://www.ukhealthcaregazette.com/article/811050748-h-e-a-l-t-h-for-youths-passport-to-health-fair UK Healthcare Gazette en PressRelease 2026-04-24T04:49:40+00:00 H.E.A.L.T.H for Youths Passport to Health Fair https://www.ukhealthcaregazette.com/article/907759706-indivior-presents-new-real-world-data-at-asam-2026-annual-conference-supporting-remission-as-a-treatment-outcome-and-reinforcing-the-clinical UK Healthcare Gazette en PressRelease 2026-04-24T15:00:00+00:00 Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://www.ukhealthcaregazette.com/article/907694179-amphista-therapeutics-announces-presentation-of-new-preclinical-data-from-its-smarca2-and-tead-targeted-glue-degrader-programs-at-aacr-2026-and UK Healthcare Gazette en PressRelease 2026-04-24T08:00:27+00:00 Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program https://ml-eu.globenewswire.com/media/d3d2174f-591e-4e13-9a89-363dcbfe5c68/small/amphista-horiz-logo-rgb-1500px-png.png https://www.ukhealthcaregazette.com/article/907693813-levicept-to-present-data-from-phase-ii-study-of-levi-04-at-oarsi-2026-world-congress-on-osteoarthritis UK Healthcare Gazette en PressRelease 2026-04-24T08:00:00+00:00 Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis https://ml-eu.globenewswire.com/media/44086146-ae7c-40ad-9e1d-326ca3bfbf7e/small/levicept-logo-png.png